FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1924942058> ?p ?o ?g. }

• W1924942058 endingPage "2540" @default.
• W1924942058 startingPage "2532" @default.
• W1924942058 abstract "BACKGROUND Androgen receptor (AR) expression in breast cancers may serve as a prognostic and predictive marker. We examined the expression pattern of AR and its phosphorylated forms, Ser‐213 (AR‐Ser[P]‐213) and Ser‐650 (AR‐Ser[P]‐650), in breast cancer and evaluated their association with clinicopathological parameters. METHODS Immunohistochemistry was performed on primary and distant metastatic breast cancers and benign breast tissue using antibodies against AR, AR‐Ser(P)‐213, and AR‐Ser(P)‐650. The levels of cytoplasmic and nuclear expression were scored semiquantitatively using a histoscore. RESULTS Nuclear staining of AR was observed in all benign breast tissue and 67% of cancer cases. Nuclear and cytoplasmic AR‐Ser(P)‐213 was increased in breast cancers 2‐fold ( P = .0014) and 1.7‐fold ( P = .05), respectively, compared with benign controls, whereas nuclear and cytoplasmic AR‐Ser(P)‐650 expression was decreased in tumors by 1.9‐fold and 1.7‐fold (both P < .0001), respectively. Increased expression of nuclear or cytoplasmic AR‐Ser(P)‐213 was observed in metastatic breast cancers (1.3‐fold, P = .05), ER‐negative (2.6‐fold, P = .001), and invasive ductal carcinoma (6.8‐fold, P = .04). AR‐Ser(P)‐650 expression was downregulated in lymph node‐positive breast cancers (1.4‐fold, P = .02) but was upregulated in invasive ductal carcinomas (3.2‐fold, P < .0001) and metastases (1.5‐fold, P = .003). Moreover, in ER‐negative breast cancers, nuclear AR‐Ser(P)‐650 was decreased (1.4‐fold, P = .005), and cytoplasmic AR‐Ser(P)‐650 was increased (1.4‐fold, P = .003). CONCLUSIONS AR and its phosphorylation at serines 213 and 650 are differentially expressed in breast cancer tumorigenesis and progression. Phosphorylation of AR at serines 213 and 650 is increased in ER‐negative breast cancers, ductal carcinomas, and metastases and may have predictive value in breast cancer prognosis. Cancer 2013;119:2532–2540 . © 2013 American Cancer Society ." @default.
• W1924942058 created "2016-06-24" @default.
• W1924942058 creator A5003892273 @default.
• W1924942058 creator A5006114431 @default.
• W1924942058 creator A5009486201 @default.
• W1924942058 creator A5010536553 @default.
• W1924942058 creator A5010725142 @default.
• W1924942058 creator A5011447518 @default.
• W1924942058 creator A5014353611 @default.
• W1924942058 creator A5015295981 @default.
• W1924942058 creator A5021774265 @default.
• W1924942058 creator A5024176882 @default.
• W1924942058 creator A5044212870 @default.
• W1924942058 creator A5060305478 @default.
• W1924942058 creator A5067230136 @default.
• W1924942058 date "2013-04-19" @default.
• W1924942058 modified "2023-10-15" @default.
• W1924942058 title "Expression of androgen receptor and its phosphorylated forms in breast cancer progression" @default.
• W1924942058 cites W1971566553 @default.
• W1924942058 cites W1972659703 @default.
• W1924942058 cites W1974738527 @default.
• W1924942058 cites W1987117672 @default.
• W1924942058 cites W2015784383 @default.
• W1924942058 cites W2022939574 @default.
• W1924942058 cites W2026802581 @default.
• W1924942058 cites W2033997062 @default.
• W1924942058 cites W2043152591 @default.
• W1924942058 cites W2043959415 @default.
• W1924942058 cites W2044638220 @default.
• W1924942058 cites W2054388347 @default.
• W1924942058 cites W2058028034 @default.
• W1924942058 cites W2074619468 @default.
• W1924942058 cites W2080643840 @default.
• W1924942058 cites W2084715195 @default.
• W1924942058 cites W2086583846 @default.
• W1924942058 cites W2091926537 @default.
• W1924942058 cites W2095933146 @default.
• W1924942058 cites W2122100237 @default.
• W1924942058 cites W2126071672 @default.
• W1924942058 cites W2131422252 @default.
• W1924942058 cites W2138602205 @default.
• W1924942058 cites W2162765338 @default.
• W1924942058 cites W2170232533 @default.
• W1924942058 cites W3126209173 @default.
• W1924942058 doi "https://doi.org/10.1002/cncr.28092" @default.
• W1924942058 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3874891" @default.
• W1924942058 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23605249" @default.
• W1924942058 hasPublicationYear "2013" @default.
• W1924942058 type Work @default.
• W1924942058 sameAs 1924942058 @default.
• W1924942058 citedByCount "18" @default.
• W1924942058 countsByYear W19249420582013 @default.
• W1924942058 countsByYear W19249420582014 @default.
• W1924942058 countsByYear W19249420582015 @default.
• W1924942058 countsByYear W19249420582016 @default.
• W1924942058 countsByYear W19249420582017 @default.
• W1924942058 countsByYear W19249420582018 @default.
• W1924942058 countsByYear W19249420582019 @default.
• W1924942058 countsByYear W19249420582020 @default.
• W1924942058 countsByYear W19249420582023 @default.
• W1924942058 crossrefType "journal-article" @default.
• W1924942058 hasAuthorship W1924942058A5003892273 @default.
• W1924942058 hasAuthorship W1924942058A5006114431 @default.
• W1924942058 hasAuthorship W1924942058A5009486201 @default.
• W1924942058 hasAuthorship W1924942058A5010536553 @default.
• W1924942058 hasAuthorship W1924942058A5010725142 @default.
• W1924942058 hasAuthorship W1924942058A5011447518 @default.
• W1924942058 hasAuthorship W1924942058A5014353611 @default.
• W1924942058 hasAuthorship W1924942058A5015295981 @default.
• W1924942058 hasAuthorship W1924942058A5021774265 @default.
• W1924942058 hasAuthorship W1924942058A5024176882 @default.
• W1924942058 hasAuthorship W1924942058A5044212870 @default.
• W1924942058 hasAuthorship W1924942058A5060305478 @default.
• W1924942058 hasAuthorship W1924942058A5067230136 @default.
• W1924942058 hasBestOaLocation W19249420581 @default.
• W1924942058 hasConcept C121608353 @default.
• W1924942058 hasConcept C126322002 @default.
• W1924942058 hasConcept C142724271 @default.
• W1924942058 hasConcept C204232928 @default.
• W1924942058 hasConcept C2777546739 @default.
• W1924942058 hasConcept C2780192828 @default.
• W1924942058 hasConcept C2780849966 @default.
• W1924942058 hasConcept C3018521938 @default.
• W1924942058 hasConcept C502942594 @default.
• W1924942058 hasConcept C530470458 @default.
• W1924942058 hasConcept C61367390 @default.
• W1924942058 hasConcept C71924100 @default.
• W1924942058 hasConceptScore W1924942058C121608353 @default.
• W1924942058 hasConceptScore W1924942058C126322002 @default.
• W1924942058 hasConceptScore W1924942058C142724271 @default.
• W1924942058 hasConceptScore W1924942058C204232928 @default.
• W1924942058 hasConceptScore W1924942058C2777546739 @default.
• W1924942058 hasConceptScore W1924942058C2780192828 @default.
• W1924942058 hasConceptScore W1924942058C2780849966 @default.
• W1924942058 hasConceptScore W1924942058C3018521938 @default.
• W1924942058 hasConceptScore W1924942058C502942594 @default.
• W1924942058 hasConceptScore W1924942058C530470458 @default.
• W1924942058 hasConceptScore W1924942058C61367390 @default.

• next